Suggestions
Deebie Symmes
COO/CBO and Co-founder at Aluda Pharmaceuticals, Inc.
Deebie Symmes is the Chief Operating Officer (COO), Chief Business Officer (CBO), and Co-founder of Aluda Pharmaceuticals, Inc. She has a robust background in corporate development and strategic partnerships, having successfully originated, negotiated, and closed over 50 licensing transactions across various stages of drug development, from discovery through Phase 2. Her previous roles include senior positions at companies such as Ciba Corning Diagnostics, Chiron, Tularik, and ARYx, where she was instrumental in securing a significant deal valued at $575 million that enabled an IPO.12
Symmes holds a Bachelor of Science degree in Biology from Smith College and an MBA from The Wharton School. Additionally, she completed a specialized program in Drug Development and Regulatory Science at the UCSF School of Pharmacy. Her expertise spans multiple therapeutic areas, including central nervous system (CNS), gastrointestinal (GI), cardiovascular, inflammation, and oncology.13
In her current role at Aluda, she leads efforts in corporate development, project management, communications, and fundraising, emphasizing the importance of collaborative internal teams to enhance the value of partnerships.13
